CDC approves COVID-19 vaccine for children under 5
Author
Blaire Bryant
Upcoming Events
Related News
Key Takeaways
On June 18, the U.S. Centers for Disease Control and Prevention (CDC) approved the use of COVID-19 vaccines for children aged 6 months to 5 years old, following a recommendation from the Food and Drug Administration (FDA). This approval now expands vaccine eligibility for the use of the two primary COVID-19 vaccines in the U.S. – Pfizer-BioNTech and Moderna – to nearly 20 million additional children, and makes all Americans aged 6 months and older eligible to receive a COVID-19 vaccination.
The White House has indicated that the federal government has an initial supply of approximately 10 million doses of pediatric vaccines, for which states began placing orders last month. CDC has indicated that the distribution of pediatric vaccinations for children aged 5 and under has already begun and shots will be available at local pediatric practices, pharmacies, Federally Qualified Health Centers, local health departments, clinics and other locations as early as June 20. Earlier this month, the agency updated it’s Pediatric COVID-19 Vaccination Operational Planning Guide with information on dosage ordering and a pediatric readiness checklist for local distribution.
As key providers of local public health services and frontline service providers for the medically vulnerable, counties have supported the administration of nearly 600 million vaccinations in the United States to date and will continue to play an essential role in the administration of COVID-19 vaccines and boosters.
Additional Resources
Resource
The County Role in Vaccines
Related News
Michelle Alyssa Go Act reintroduced in the 119th Congress, a critical step for county behavioral health systems
On September 18, the Michelle Alyssa Go Act was reintroduced in the U.S. House of Representatives. This bipartisan legislation aims to increase the number of federal Medicaid-eligible in-patient psychiatric beds from 16 to 36, providing critical support for individuals seeking treatment for mental health and substance use disorders.
Congress passes SUPPORT Act reauthorization
On September 18, the U.S. Senate passed the SUPPORT for Patients and Communities Reauthorization Act of 2025 (SUPPORT Act Reauthorization) (H.R. 2483) by voice vote, following House passage earlier this year. With strong bipartisan backing in both chambers, the legislation now heads to the President’s desk for signature.
CMS releases Rural Health Transformation Program funding opportunity
On September 2, the Centers for Medicare & Medicaid Services (CMS) released additional details on the Rural Health Transformation (RHT) Program, overviewing program goals, requirements and timelines.